Equities

Lyra Therapeutics Inc

LYRA:NMQ

Lyra Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.189
  • Today's Change0.007 / 3.90%
  • Shares traded1.88m
  • 1 Year change-93.86%
  • Beta-0.1141
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Lyra Therapeutics Inc (LYRA:NMQ) closed at 0.189, 16.31% above the 52 week low of 0.1625 set on Nov 18, 2024.
52-week range
Today
0.1625Nov 18 20246.79Mar 27 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.1869
High0.1977
Low0.1823
Bid0.1861
Offer0.1916
Previous close0.1819
Average volume4.35m
Shares outstanding65.46m
Free float52.27m
P/E (TTM)--
Market cap11.91m USD
EPS (TTM)-1.51
USD
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼

Events & Activity

  • LYRA:NMQ price reached a new 52-week low of 0.165 at 13:41 GMT
  • LYRA:NMQ price moved over +1.93% to 0.1733
  • LYRA:NMQ trading volume exceeds daily average by +15.02%
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.